AFLAC Incorporated · NYSE:AFL

AFLAC — Debt Investor Presentation (March 2025)

29 slides from AFLAC's debt investor presentation, Mar 23, 2025

  1. Slide 1: Debt Investor Update

    Debt Investor Update March 23, 2025

  2. Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures

    Forward-Looking Statements and Non-GAAP Financial Measures The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meani

  3. Slide 3: Aflac Incorporated Highlights

    Aflac Incorporated Highlights As of 12/31/2024 $18.9bn $7.5bn Revenues Debt1 Adjusted Pretax Earnings5 $197mm $26.1bn Interest Expense2 Book Value 29% $5.4bn 19.7% Net Earnings Adjusted Leverage3 71% Fortune World’s $4.1bn 14.4% Adjusted Earnings3 Most Admired Adjusted ROE3 Companies 2025 a A- A3 AA

  4. Slide 4: Aflac Incorporated Financial Performance

    Aflac Incorporated Financial Performance In $ millions Consolidated Earnings Adjusted Leverage1 23.0% 22.7% 36,574 5,443 34,658 34,011 33,398 32,524 4,778 4,659 4,418 4,231 20.6% 19.7% 19.7% 4,072 3,925 3,733 3,614 3,552 7,467 7,568 7,105 6,839 7,216 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024

  5. Slide 5: Aflac Japan

    Afiac. Incorporated Aflac Japan

  6. Slide 6: Aflac Japan: The Leader in Cancer and Medical Insurance in Japan

    Aflac Japan: The Leader in Cancer and Medical Insurance in Japan • Since its establishment in Japan in 1974, Aflac has developed an Over 50-years attractive product line-up and broad distribution network to become of success in Japan Japan’s leading provider of cancer and medical insurance with over

  7. Slide 7: Product Innovation - Integrating Services for Different Stages of Life

    Product Innovation - Integrating Services for Different Stages of Life Cancer Insurance Medical Insurance Asset Formation / Nursing Care • Maintaining #1 positions in the cancer insurance market • Integrated the innovative feature of • To meet the young and middle-aged • Launching a new product in s

  8. Slide 8: Broad Distribution to Reach More Customers

    Broad Distribution1 to Reach More Customers Traditional Sales Channel Alliance Partners Financial (Associates / Agencies) (Cancer Insurance) Institutions Aflac-preferred / Large Non- Japan Post Dai-ichi Life Daido Life Banks Exclusive exclusive Group • Aflac Japan’s main • Nationwide non- • Initiate

  9. Slide 9: Aflac Japan 2024 Financial Update

    Aflac Japan 2024 Financial Update Pretax Adjusted Earnings and Pretax Profit Margin1 Aflac Japan Net Earned Premiums ¥600,000 40.0% by Product ¥500,000 ¥456,859 ¥527,675 ¥411,808 ¥430,823 35.0% YTD as of 12/31/2024 36.0% ¥400,000 ¥347,881 27.7% 26.1% 30.0% Third ¥300,000 30.5% Sector 21.2% 25.0% ¥20

  10. Slide 10: Aflac U.S. Segment

    Afiac. Incorporated Aflac U.S. Segment

  11. Slide 11: Leader in U.S. Worksite Supplemental Health Insurance

    Leader in U.S. Worksite Supplemental Health Insurance1 U.S Worksite Supplemental Health Insurance Sales Market Share2 Aflac U.S. maintains its market leadership and expects to grow as we execute our strategy with a robust product portfolio that meets the customers needs • Cancer • Critical Illness O

  12. Slide 12: Aflac U.S. Growth Opportunities

    Aflac U.S. Growth Opportunities 1 Only Tier One customers are considered D2C for the purposes of this view 2 Aflac policy/certificate holders and covered employees as of December 31, 2024| Source: 2024 Bureau of Labor Statistics- Current Population Survey 12

  13. Slide 13: Aflac U.S. 2024 Financial Update

    Aflac U.S. 2024 Financial Update Pretax Adjusted Earnings and Pretax Profit Margin1 Net Earned Premiums by Product $2,000 35.0% YTD as of 12/31/2024 $1,501 $1,419 $1,500 $1,356 $1,359 30.0% $1,268 $1,000 22.7% 25.0% Accident 21.2% 20.9% 21.0% 21.1% 19.3% Dental / Vision $500 20.0% 3.4% $0 15.0% 2020

  14. Slide 14: Investment Portfolio

    Afiac. Incorporated Investment Portfolio

  15. Slide 15: Disciplined Asset Allocation and Credit Underwriting

    Disciplined Asset Allocation and Credit Underwriting As of 12/31/2024 Asset Allocation Fixed Maturities: Quality Fixed Maturities: Sector and Industry Gov’t Ag 43.6% A 68.0% Banks/Fin 10.8% Pub Util 8.4% Cons NonCyc 6.9% 5.0% A- $103 billion Average Tech 3.8% 84.7% AUM 4.5% Rating Basics 2.5% 1.6% T

  16. Slide 16: Aflac Commercial Real Estate Loan Portfolio

    Aflac Commercial Real Estate Loan Portfolio As of 12/31/2024 16

  17. Slide 17: Capital Management

    Afiac. Incorporated Capital Management

  18. Slide 18: Strong Capital Ratios

    Strong Capital Ratios1 Japan U.S. 677% >270% 450 230 350 170 ESRe1 Combined RBC Ratio2 (Japan) (U.S.) 1 Estimated regulatory ESR with undertaking-specific parameter (USP), sensitivities produced by internal model result in a slightly more conservative outcome, i.e., a greater sensitivity to all vari

  19. Slide 19: Key Credit Highlights

    Key Credit Highlights 1 Leading provider of supplemental health insurance in the U.S. and Japan 2 Diverse, broad distribution supported by well-recognized, reputable brand Strong, consistent earnings generation backing the Company’s ability to service 3 debt and tactically, opportunistically deploy

  20. Slide 20: Appendix

    Afiac. Incorporated Appendix

  21. Slide 21: Aflac U.S. Insurance Products

    Aflac U.S. Insurance Products • Pays cash benefits in the event of a covered injury. The accident portion of the policy Accident includes lump-sum benefits for accidental death, dismemberment and specific injuries as well as fixed benefits for hospital confinement • Offers short-term disability bene

  22. Slide 22: Aflac Middle Market Loan Portfolio

    Aflac Middle Market Loan Portfolio As of 12/31/2024 26

  23. Slide 23: Glossary of Non-U.S. GAAP Measures

    Glossary of Non-U.S. GAAP Measures The Company defines these non-U.S. GAAP financial measures as follows: • Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted ave

  24. Slide 24: Glossary of Non-U.S. GAAP Measures

    Glossary of Non-U.S. GAAP Measures The Company defines these non-U.S. GAAP financial measures as follows: • Adjusted return on equity is annualized adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on e

  25. Slide 25: Effect of Foreign Currency on Adjusted Results

    Effect of Foreign Currency on Adjusted Results Year ended December 31, 2024 Including Excluding Currency Currency2 Net premium income3 (4.8)% (0.6)% Adjusted net investment income1 12.1% 14.1% Total benefits and expenses (7.3)% (3.3)% Adjusted earnings1 9.1% 11.8% Adjusted earnings per diluted share

  26. Slide 26: Reconciliation of U.S. GAAP Return on Equity to Adjusted ROE

    Reconciliation of U.S. GAAP Return on Equity to Adjusted ROE Twelve Months Ended December 31, in millions of Dollars 2024 2023 U.S. GAAP ROE - Net earnings1 22.6% 22.1% Impact of excluding unrealized foreign currency translation gains (losses) (3.6) (3.1) Impact of excluding unrealized gains (losses

  27. Slide 27: Reconciliation of Net Earnings to Adjusted Earnings

    Reconciliation of Net Earnings to Adjusted Earnings1 Year ended December 31 in millions of Dollars 2024 2023 % Change Net earnings $5,443 $4,659 16.8% Items impacting net earnings: Adjusted net investment (gains) losses (1,495) (914) Other and non-recurring (income) loss 23 (39) Income tax (benefit)

  28. Slide 28: Adjusted Leverage Ratios

    Adjusted Leverage Ratios (In millions) 2024 2023 Notes Payable $7,498 $7,364 50% of subordinated debentures and perpetual bonds (282) (315) Pre-funding of debt maturities — (211) Adjusted debt1 7,216 6,839 Total Shareholders’ Equity 26,098 21,985 Accumulated other comprehensive (income)loss: Unreali

  29. Slide 29: Learn more: investors.aflac.com Contact us

    Learn more: investors.aflac.com Contact us: Aflac Incorporated Investor and Rating Agency Relations 1932 Wynnton Road Columbus, GA 31999 tel: 706.596.3264 or 800.235.2667 or 011.81.3.3344.0481 in Japan AflacIR@aflac.com

Aflac — Debt Investor Presentation (March 2025) on 6ix